Diabetes Mellitus ( ISSN:2072-0351, E-ISSN:2072-0378) is a peer-reviewed scopus-indexed journal from 2012 to present. The publisher of this journal is Russian Association of Endocrinologists. Diabetes Mellitus committed to gathering and disseminating excellent research achievements. The journal welcomes all types of Medicine journal includes General Medicine, Internal Medicine, Endocrinology, Diabetes and Metabolism, Biochemistry, Genetics and Molecular Biology .
Submission Date
Valunteer
DM-06-08-2025-7140
Diabetes Mellitus
Psychoorganic syndrome (POS), also known as encephalopathy, is characterized by cognitive decline, emotional incontinence (emotional lability), and asthenic symptoms. It can develop as a result of a number of exogenous and endogenous factors, and despite the use of the term "diabetic encephalopathy", evidence for the existence of a specific diabetic genesis of POS remains limited. The
DM-06-08-2025-7139
Diabetes Mellitus
Therapeutic education of patients with diabetes mellitus (DM) has become an important and mandatory component of the comprehensive treatment of this disease. This approach combines several disciplines, such as medicine, pedagogy and psychology, which makes it a unique field aimed at improving the health and quality of life of patients. The goal of therapeutic education is not only to provide in
DM-06-08-2025-7138
Diabetes Mellitus
Type 1 diabetes mellitus (T1DM) in childhood is one of the most important social and medical problems, given the growing incidence and negative impact on the duration and quality of life. The onset of the disease in childhood associated with significantly reduced life expectancy, largely due to micro- and macrovascular complications, and background pathological processes may occur from the T1DM
DM-06-08-2025-7136
Diabetes Mellitus
To investigate the heterogeneity of autoimmune diabetes mellitus (DM) in adults and identify factors associated with delayed initiation of insulin therapy in real-world clinical practice. A retrospective analysis was conducted on clinical and laboratory data from 717 patients with DM onset after the age of 18 who were tested for antibodies against β-cell antigens (GAD, IA-2, ICA, ZnT8, ins
DM-06-08-2025-7135
Diabetes Mellitus
Latent autoimmune diabetes mellitus in adults (LADA) is considered an intermediate form between type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM), but the molecular mechanisms that explain its unique clinical and pathogenetic features remain poorly understood. Determination of differentially expressed genes (DEGs) in LADA compared to T1DM is necessary to develop more personali